Abstract
There are several reports that angiogenesis plays important roles in hematological malignancies including acute myeloid leukemia (AML). Human interleukin‐17 (IL‐17) is a proinflammatory cytokine produced by activated CD4 T cells. IL‐17 plays a potential role in T cell mediated angiogenesis. The role of IL‐17 in pathologic angiogenesis has not been evaluated yet. The aim of the study was to determine plasma level of IL‐17 in patients with AML. IL‐17 levels were measured by ELISA in plasma samples taken from 68 adult patients with AML before chemotherapy was administered. In addition 20 out of 68 patients were reanalysed after achieving complete remission (CR). Ten samples from healthy volunteers were evaluated as the control. In this study we have demonstrated that serum level of IL‐17 is not elevated in AML patients. These results suggest that angiogenesis in AML is not mediated by CD4 T cells. To our knowledge this is the first report about IL‐17 serum level in acute leukemias. We are currently evaluating IL‐17 levels in others haematological malignancies.
Keywords: interleukin 17, angiogenesis, acute myeloid leukemia
References
- 1. Folkman J., Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat. Med., 1: 27–31, 1995. [DOI] [PubMed] [Google Scholar]
- 2. Hussong J.W., Rodgers G.M., Shami P.J., Evidence of increased angiogenesis in patients with acute myeloid leukemia, Blood, 95: 309–313, 2000. [PubMed] [Google Scholar]
- 3. Yang R.B., Domingos C.K., Wasserman S.M., Kömüves L.G., Gerritsen M.E., Topper J.N., A novel Interleukin‐17 receptor‐like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor‐induced signaling. J. Biol. Chem., 278: 33232–33238, 2003. [DOI] [PubMed] [Google Scholar]
- 4. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., Fujiyama Y., Increased expression of interleukin 17 in inflammatory bowel disease, Gut, 52: 65–73, 2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Numasaki M., Fukushi J., Ono M., Narula S.K., Zavodny P.J., Kudo T., Robbins P.D., Tahara H., Lotze M.T., Interleukin‐17 promotes angiogenesis and tumor growth, Blood, 101: 2620–2627, 2003. [DOI] [PubMed] [Google Scholar]
- 6. Padro T., Ruiz S., Bieker R., Burger H., Steins M., Kienast J., Buchner T., Berdel W.E., Mesters R.M., Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood, 95: 2637–2644, 2000. [PubMed] [Google Scholar]
- 7. Aguayo A., Kantarijan H., Manshouri T., Gidel C., Estey E., Thomas D., Koller Ch., Estrov Z, O'Brien S., Keating M., Freireich E., Albitar M., Cellular vascular endothelial growth factor is a predictor of outcome in pastients with acute myeloid leukemia, Blood, 96: 2240–2245, 2000. [PubMed] [Google Scholar]
- 8. Di Raimondo F., Azzaro M.P., Palumbo G.A., Bagnato S., Giustolisi G., Florida P.M., Sortino G., Giustolisi R., Angiogenic factors in mutliple myeloma: higher levels in bone marrow than in peripheral blood, Haematologica, 85: 800–805, 2000. [PubMed] [Google Scholar]